Interview: Measured Launch, Long Future For Gilead CAR-T In Europe

 
• By Eleanor Malone

Positive recommendations for the approval of CAR-T therapies Yescarta and Kymriah were delivered in Europe in June. Michael Elliott, Gilead Sciences' VP for medical affairs in Europe, spoke to Scrip about the Yescarta launch strategy and the long-term future of CAR-T.

Truck
Gilead is preparing for the long road in CAR-T • Source: Shutterstock

More from New Products

More from Scrip